Opko Health Inc. (NASDAQ:OPK) shares traded down 1.9% during trading on Thursday . The stock traded as low as $3.39 and last traded at $3.33. 2,154,033 shares were traded during mid-day trading, a decline of 54% from the average session volume of 4,691,112 shares. The stock had previously closed at $3.39.
Several research analysts recently commented on the stock. BidaskClub downgraded shares of Opko Health from a “sell” rating to a “strong sell” rating in a report on Wednesday, January 10th. Zacks Investment Research downgraded shares of Opko Health from a “hold” rating to a “sell” rating in a report on Thursday, January 11th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $13.34.
The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.48 and a current ratio of 1.66. The stock has a market cap of $1,820.00, a price-to-earnings ratio of -16.74 and a beta of 1.42.
Several hedge funds and other institutional investors have recently bought and sold shares of OPK. Ellington Management Group LLC bought a new stake in shares of Opko Health during the 4th quarter worth $112,000. Crossmark Global Holdings Inc. bought a new stake in shares of Opko Health during the 3rd quarter worth $118,000. State of Alaska Department of Revenue bought a new stake in shares of Opko Health during the 4th quarter worth $144,000. The Manufacturers Life Insurance Company lifted its holdings in shares of Opko Health by 7.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,535 shares of the biotechnology company’s stock worth $149,000 after acquiring an additional 1,657 shares during the last quarter. Finally, First Trust Advisors LP bought a new stake in shares of Opko Health during the 4th quarter worth $154,000. 22.22% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Opko Health (OPK) Trading Down 1.9%” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3231197/opko-health-opk-trading-down-1-9.html.
Opko Health Company Profile
OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.
Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.